Apoptosis-inducing factor of a cytotoxic T cell line: involvement of a secretory phospholipase A2

Helio M Costa-Junior1, Flávia C Hamaty, Rafael da Silva Farias

  • 1Laboratório de Imunobiofísica, Instituto de Biofísica Carlos Chagas Filho - UFRJ, Universidade Federal do Rio de Janeiro, Bloco G do CCS - Ilha do Fundão, 21941-590, Rio de Janeiro, Brazil.

Insights

Secretory phospholipase A(2) (sPLA(2)) induces apoptosis in cytotoxic T lymphocytes (CTLs) via a Ca(2+)-dependent pathway. This cytosolic sPLA(2) plays a key role in CTL-mediated cell killing.

Area of Science:

  • Immunology
  • Cell Biology
  • Enzymology

Background:

  • Cytotoxic T lymphocytes (CTLs) eliminate target cells through granule-exocytosis and TNF-family molecules.
  • Secretory phospholipase A(2) (sPLA(2)) involvement in Natural Killer (NK) cell cytotoxicity is suggested, but its identity and role are unclear.

Purpose of the Study:

  • To investigate the molecular identity, localization, and mechanism of action of sPLA(2) in CTL-mediated cytotoxicity.
  • To determine if sPLA(2) contributes to CTL-induced apoptosis.

Main Methods:

  • Studied cytotoxic activity of CTL extracts after inactivating the perforin-granzyme pathway.
  • Utilized Ca(2+) dependency, temperature resistance, and sPLA(2) inhibitors (4-bromophenacyl bromide, scalaradial) to assess sPLA(2) activity.
  • Employed cell fractionation and Western blotting to determine sPLA(2) localization and molecular weight.

Main Results:

  • CTL extracts, when perforin-granzyme pathways were inhibited, showed enhanced Ca(2+)-dependent, thermo-resistant apoptosis-inducing activity.
  • This activity was blocked by sPLA(2) inhibitors and an anti-sPLA(2) antibody.
  • Cell fractionation revealed pro-apoptotic sPLA(2) in the cytoplasmic fraction, not in granules or plasma membranes.
  • Western blotting detected sPLA(2) bands, with the largest consistent with group III sPLA(2).

Conclusions:

  • An apoptosis-inducing sPLA(2) is present in the cytosol of CTLs.
  • This cytosolic sPLA(2) appears to function as an effector molecule in CTL-mediated cytotoxicity.

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized by phagocytes.
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...